How the need for biopharma innovation extends to questions around executive compensation.
Carl Sjostrom and Ian Wilcox
Advertisement
Carl Sjostrom is a Senior Advisor at Viti Solutions. He can be reached at carl@vitisolutions.comIan Wilcox is a Managing Partner at Cogitari Advisors, LLC. He can be reached at ian@cogitariadvisors.com
Articles by Carl Sjostrom and Ian Wilcox
Advertisement
Latest Updated Articles
Executive Pay and InnovationPublished: December 9th 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
3
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
4
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
5
